Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Apixaban | Apixaban may increase the anticoagulant activities of Tocopherylquinone. |
| Dabigatran etexilate | Dabigatran etexilate may increase the anticoagulant activities of Tocopherylquinone. |
| Dasatinib | The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Tocopherylquinone. |
| Deferasirox | The risk or severity of gastrointestinal bleeding can be increased when Tocopherylquinone is combined with Deferasirox. |
| Ursodeoxycholic acid | The risk or severity of bleeding and bruising can be increased when Tocopherylquinone is combined with Ursodeoxycholic acid. |
| Glycochenodeoxycholic Acid | The risk or severity of bleeding and bruising can be increased when Tocopherylquinone is combined with Glycochenodeoxycholic Acid. |
| Cholic Acid | The risk or severity of bleeding and bruising can be increased when Tocopherylquinone is combined with Cholic Acid. |
| Glycocholic acid | The risk or severity of bleeding and bruising can be increased when Tocopherylquinone is combined with Glycocholic acid. |
| Deoxycholic acid | The risk or severity of bleeding and bruising can be increased when Tocopherylquinone is combined with Deoxycholic acid. |
| Taurocholic acid | The risk or severity of bleeding and bruising can be increased when Tocopherylquinone is combined with Taurocholic acid. |
| Obeticholic acid | The risk or severity of bleeding and bruising can be increased when Tocopherylquinone is combined with Obeticholic acid. |
| Chenodeoxycholic acid | The risk or severity of bleeding and bruising can be increased when Tocopherylquinone is combined with Chenodeoxycholic acid. |
| Taurochenodeoxycholic acid | The risk or severity of bleeding and bruising can be increased when Tocopherylquinone is combined with Taurochenodeoxycholic acid. |
| Tauroursodeoxycholic acid | The risk or severity of bleeding and bruising can be increased when Tocopherylquinone is combined with Tauroursodeoxycholic acid. |
| Bamet-UD2 | The risk or severity of bleeding and bruising can be increased when Tocopherylquinone is combined with Bamet-UD2. |
| Dehydrocholic acid | The risk or severity of bleeding and bruising can be increased when Tocopherylquinone is combined with Dehydrocholic acid. |
| Hyodeoxycholic Acid | The risk or severity of bleeding and bruising can be increased when Tocopherylquinone is combined with Hyodeoxycholic Acid. |
| Edoxaban | The risk or severity of bleeding can be increased when Edoxaban is combined with Tocopherylquinone. |
| Ibrutinib | The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Tocopherylquinone. |
| Rivaroxaban | Tocopherylquinone may increase the anticoagulant activities of Rivaroxaban. |
| Sugammadex | The risk or severity of bleeding and hemorrhage can be increased when Tocopherylquinone is combined with Sugammadex. |
| Tibolone | Tibolone may increase the anticoagulant activities of Tocopherylquinone. |
| Tipranavir | The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Tocopherylquinone. |
| Urokinase | Urokinase may increase the anticoagulant activities of Tocopherylquinone. |
| Vitamin E | Vitamin E may increase the anticoagulant activities of Tocopherylquinone. |
| Vorapaxar | The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Tocopherylquinone. |
| Alfuzosin | Alfuzosin may increase the hypotensive activities of Tocopherylquinone. |
| Amifostine | Tocopherylquinone may increase the hypotensive activities of Amifostine. |
| Diazoxide | Diazoxide may increase the hypotensive activities of Tocopherylquinone. |
| Methylphenidate | Methylphenidate may decrease the antihypertensive activities of Tocopherylquinone. |
| Dexmethylphenidate | Dexmethylphenidate may decrease the antihypertensive activities of Tocopherylquinone. |
| Obinutuzumab | Tocopherylquinone may increase the hypotensive activities of Obinutuzumab. |
| Rituximab | Tocopherylquinone may increase the hypotensive activities of Rituximab. |
| Desmopressin | Desmopressin may decrease the antihypertensive activities of Tocopherylquinone. |
| Cyclosporine | Cyclosporine may decrease the antihypertensive activities of Tocopherylquinone. |
| Phentermine | Phentermine may decrease the antihypertensive activities of Tocopherylquinone. |
| Midodrine | Midodrine may decrease the antihypertensive activities of Tocopherylquinone. |
| Eletriptan | Eletriptan may decrease the antihypertensive activities of Tocopherylquinone. |
| Isoetharine | Isoetharine may decrease the antihypertensive activities of Tocopherylquinone. |
| Methysergide | Methysergide may decrease the antihypertensive activities of Tocopherylquinone. |
| Cabergoline | Cabergoline may decrease the antihypertensive activities of Tocopherylquinone. |
| Atomoxetine | Atomoxetine may decrease the antihypertensive activities of Tocopherylquinone. |
| Etomidate | Etomidate may decrease the antihypertensive activities of Tocopherylquinone. |
| Zolmitriptan | Zolmitriptan may decrease the antihypertensive activities of Tocopherylquinone. |
| Dihydroergotamine | Dihydroergotamine may decrease the antihypertensive activities of Tocopherylquinone. |
| Amitriptyline | Amitriptyline may decrease the antihypertensive activities of Tocopherylquinone. |
| Protriptyline | Protriptyline may decrease the antihypertensive activities of Tocopherylquinone. |
| Methylergometrine | Methylergometrine may decrease the antihypertensive activities of Tocopherylquinone. |
| Norepinephrine | Norepinephrine may decrease the antihypertensive activities of Tocopherylquinone. |
| Mirtazapine | Mirtazapine may decrease the antihypertensive activities of Tocopherylquinone. |
| Phenylephrine | Phenylephrine may decrease the antihypertensive activities of Tocopherylquinone. |
| Phenylpropanolamine | Phenylpropanolamine may decrease the antihypertensive activities of Tocopherylquinone. |
| Promazine | Promazine may decrease the antihypertensive activities of Tocopherylquinone. |
| Droperidol | Droperidol may decrease the antihypertensive activities of Tocopherylquinone. |
| Buspirone | Buspirone may decrease the antihypertensive activities of Tocopherylquinone. |
| Nortriptyline | Nortriptyline may decrease the antihypertensive activities of Tocopherylquinone. |
| Amoxapine | Amoxapine may decrease the antihypertensive activities of Tocopherylquinone. |
| Doxapram | Doxapram may decrease the antihypertensive activities of Tocopherylquinone. |
| Atropine | Atropine may decrease the antihypertensive activities of Tocopherylquinone. |
| Lisuride | Lisuride may decrease the antihypertensive activities of Tocopherylquinone. |
| Metaraminol | Metaraminol may decrease the antihypertensive activities of Tocopherylquinone. |
| Epinephrine | Epinephrine may decrease the antihypertensive activities of Tocopherylquinone. |
| Sumatriptan | Sumatriptan may decrease the antihypertensive activities of Tocopherylquinone. |
| Ergotamine | Ergotamine may decrease the antihypertensive activities of Tocopherylquinone. |
| Nicergoline | Nicergoline may decrease the antihypertensive activities of Tocopherylquinone. |
| Methoxamine | Methoxamine may decrease the antihypertensive activities of Tocopherylquinone. |
| Trimipramine | Trimipramine may decrease the antihypertensive activities of Tocopherylquinone. |
| Risperidone | Risperidone may decrease the antihypertensive activities of Tocopherylquinone. |
| Propiomazine | Propiomazine may decrease the antihypertensive activities of Tocopherylquinone. |
| Alfentanil | Alfentanil may decrease the antihypertensive activities of Tocopherylquinone. |
| Fentanyl | Fentanyl may decrease the antihypertensive activities of Tocopherylquinone. |
| Orciprenaline | Orciprenaline may decrease the antihypertensive activities of Tocopherylquinone. |
| Phenmetrazine | Phenmetrazine may decrease the antihypertensive activities of Tocopherylquinone. |
| Trifluoperazine | Trifluoperazine may decrease the antihypertensive activities of Tocopherylquinone. |
| Dobutamine | Dobutamine may decrease the antihypertensive activities of Tocopherylquinone. |
| Pseudoephedrine | Pseudoephedrine may decrease the antihypertensive activities of Tocopherylquinone. |
| Benzphetamine | Benzphetamine may decrease the antihypertensive activities of Tocopherylquinone. |
| Ritodrine | Ritodrine may decrease the antihypertensive activities of Tocopherylquinone. |
| Terbutaline | Terbutaline may decrease the antihypertensive activities of Tocopherylquinone. |
| Flupentixol | Flupentixol may decrease the antihypertensive activities of Tocopherylquinone. |
| Bitolterol | Bitolterol may decrease the antihypertensive activities of Tocopherylquinone. |
| Almotriptan | Almotriptan may decrease the antihypertensive activities of Tocopherylquinone. |
| Diethylpropion | Diethylpropion may decrease the antihypertensive activities of Tocopherylquinone. |
| Salmeterol | Salmeterol may decrease the antihypertensive activities of Tocopherylquinone. |
| Naratriptan | Naratriptan may decrease the antihypertensive activities of Tocopherylquinone. |
| Rizatriptan | Rizatriptan may decrease the antihypertensive activities of Tocopherylquinone. |
| Formoterol | Formoterol may decrease the antihypertensive activities of Tocopherylquinone. |
| Dopamine | Dopamine may decrease the antihypertensive activities of Tocopherylquinone. |
| Frovatriptan | Frovatriptan may decrease the antihypertensive activities of Tocopherylquinone. |
| Albuterol | Salbutamol may decrease the antihypertensive activities of Tocopherylquinone. |
| Methoxyflurane | Methoxyflurane may decrease the antihypertensive activities of Tocopherylquinone. |
| Ergoloid mesylate | Ergoloid mesylate may decrease the antihypertensive activities of Tocopherylquinone. |
| Isoprenaline | Isoprenaline may decrease the antihypertensive activities of Tocopherylquinone. |
| Arbutamine | Arbutamine may decrease the antihypertensive activities of Tocopherylquinone. |
| Dutasteride | Dutasteride may decrease the antihypertensive activities of Tocopherylquinone. |
| Doxepin | Doxepin may decrease the antihypertensive activities of Tocopherylquinone. |
| Desipramine | Desipramine may decrease the antihypertensive activities of Tocopherylquinone. |
| Propafenone | Propafenone may decrease the antihypertensive activities of Tocopherylquinone. |
| Pergolide | Pergolide may decrease the antihypertensive activities of Tocopherylquinone. |
| Finasteride | Finasteride may decrease the antihypertensive activities of Tocopherylquinone. |